| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 14.0K | 15.0% | 32.2% |
| Total Income | 14.0K | 15.3% | 32.4% |
| Expenditure | 12.3K | 15.3% | 30.1% |
| PBT | 1.8K | 22.7% | 61.8% |
| Net Profit | 1.3K | 5.2% | 45.9% |
| OPM | — | ||
| NPM | 9.17% | 0.87pp | 0.85pp |
| EPS | 4.71 | 5.6% | 44.0% |
Detailed report is being prepared.
Growth Momentum Tested: Can Aditya Birla Capital Sustain Q1's 40% Profit Surge?
The financial services conglomerate reported a stellar Q1 FY27—PAT +40%, revenue +29%, lending portfolio +32%. Q2 will test whether that momentum holds amid an aggressive capital raise and a tightening funding environment. All-in Street view: buy on dips.
The Setup
Aditya Birla Capital enters Q2 FY27 on a confidence high. Q1 printed a 40% year-on-year profit surge to ₹1,175 Cr, revenue up 29% to ₹14,731 Cr, and total lending portfolio expanding 32% to ₹2,19,289 Cr. The insurance arm—both life and health—accelerated sharply (life FYP +20%, health GWP +50%). A ₹4,000 Cr preferential capital raise from promoters and IFC, plus ₹3,000+ Cr in fresh NCD issuances through September, signal the company is ready to deploy. The question for Q2: does execution hold, or does growth moderate as funding tightens and base comparisons stiffen?
~₹1,000–1,100 Cr
Growth momentum from Q1 +40% likely continues but may moderate to +20–30% YoY as comparisons stiffen
~₹14,500–15,000 Cr
Expect +20–25% YoY; lending and insurance contributions both tracking well
~₹2,25,000–2,30,000 Cr
Track the 32% YoY growth from Q1; gold loan ramp-up (new business) may show in originations or pipeline
~₹7,70,000–7,85,000 Cr
+36% YoY from Q1; insurance and mutual fund flows likely continued
What Matters Most
Profit growth trajectory: The ₹1,175 Cr Q1 result raised expectations materially. Street is pricing in a sustainable 20–30% annual profit growth rate. Q2 will reveal whether margins hold—watch net interest margin (NIM) in the lending book and commission mix in insurance, especially life. Portfolio quality: With rapid growth, asset-quality trends (NIL/slippages in the lending portfolio) are critical. A clean slate will reassure on sustainability; any deterioration would be a red flag. Capital deployment: The ₹4,000 Cr raise signals NBFC expansion plans. Early deployment visibility or guidance on target AUM/loan book for FY27 would help validate the growth rate. Gold loan ramp: The August launch of 200–300 gold loan branches by March 2027 is a greenfield opportunity. Any colour on branch openings, policy mix, or yield expectations would move the dial.
On Track for Guidance?
Prior guidance is unverified against actuals in our DB, so we judge Q2 on its own trajectory relative to Q1 and the full-year setup. The Q1 performance—40% profit growth across a broad base (lending +32%, AUM +36%, insurance double-digit premiums)—suggests the company is executing faster than the Street consensus may have assumed at the start of the year. If Q2 shows ≥20% YoY profit growth and lending portfolio growth stays 25%+, the FY27 full-year 20–25% profit-growth guidance would be on track. Watch for any management commentary on FY27 loan-book growth, margin targets, or insurance premium-growth expectations in the earnings call.
Since Last Quarter: The Filings
1 · Capital raises: Aggressive NCD issuance
Between August and October 2026, ABCL issued ₹3,000+ Cr in fresh NCDs across multiple tranches (₹1,935 Cr private placement on Sep 9; ₹300 Cr on Sep 2; ₹192 Cr subordinated on Sep 23; ₹500 Cr on Sep 28; ₹400 Cr on Oct 15). Coupled with the ₹4,000 Cr preferential share allotment in Q1, total capital raised this half is ~₹7,000 Cr. Watch the deployment pace—rapid deployment signals confidence; delays could point to slowing originations or execution challenges.
2 · Gold loan business: New growth vector
Launched on 2026-08-20. Plans call for 200–300 dedicated branches by March 2027. Gold loans are typically lower-risk, higher-yield products. Any branch-count or loan-book colour in the Q2 call would be a positive catalyst; absence of detail might suggest slower ramp than expected.
3 · Management: CTO appointment
Subhash Subramaniam appointed Chief Technology Officer effective 2026-08-03. Routine organizational move; no material risk.
4 · Insider activity: Trading window closed
Trading window for designated persons and relatives closed on 2026-10-01 in advance of Q2 results (due 2026-10-30). Routine SEBI compliance; no unusual pledges or insider selling detected in block deals.
5 · Bulk deals: Passive accumulation
On 2026-10-21, PI Opportunities AIF V LLP acquired 30.67 L shares @ ₹366 (block buy); same counterparty sold to Prazim Trading & Investment on the same day (likely a reorganization). No red flags; normal institutional rebalancing.
The Watch List: What to Track on Result Day
1 · PAT growth rate—is Q1's +40% sustainable?
Expect ₹1,000–1,100 Cr (YoY +20–30%). A print >₹1,100 Cr would be a positive surprise; <₹950 Cr would signal margin or growth pressure. Listen for management commentary on full-year profit guidance.
2 · Lending portfolio momentum: growth rate and asset quality
Q1 was +32% YoY. Expect Q2 to hold 25–30% growth. Watch gross/net NPA ratio and slippage—any deterioration (>100 bps YoY) would pressure multiples despite revenue growth.
3 · Capital deployment roadmap for H2 and FY28
With ₹7,000 Cr raised, management commentary on target loan-book AUM, branch expansion (gold loan and others), and expected yields would validate the growth thesis. Absence of detail or guidance conservatism could invite profit-taking despite the Street's bullish setup.
Aditya Birla Capital enters Q2 as a growth story under pressure: strong Q1 momentum and massive capital infusion sit against a rising funding cost environment and a stock trading at technical lows (RSI 29). The earnings preview hinges on three pillars: (1) proof of 20%+ PAT growth run-rate, (2) sustained lending portfolio expansion without asset-quality deterioration, and (3) visibility on capital deployment in H2 FY27. The Street is 100% bullish at ₹417.50 median target; if Q2 prints clean numbers on all three, the stock could re-rate sharply. Execution miss on any one would bring sellers into what looks like a consensus call.
Watch the numbers. Then listen to the tone.